Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- Why Some Brains Switch Gears More Efficiently Than Others.
- Health Policy Experts Identify Promising Strategies for Providing Health Care to Homeless People.
- NIH F Grant Writing Workshop 4/30 – Register by 4/27
- The Research that Got Sick Veterans Treatment.
Categories
- Community (2,472)
- Covid (999)
- CTO Events (6)
- News (3,133)
- Pilots (21)